Ah, thanks. I saw that one - device company. IBIO is certainly in a different class, however. I think they are a perfect buyout candidate IMO. Also, speaking of device, NSPH may also get into that mix at some point, since while companies like IBIO can help fast track the vaccines, in the meantime, there needs to be better diagnostic devices. Amazing...people are saying the EBOLA stocks are done...but if EBOLA isn't done, and our esteemed government has put a gag order on the press to report anymore suspected cases, then IMO this disease could lurk, sneak up on our entire society, and explode overnight...and with it, all these stocks. Precarious times for sure...I'm sticking with IBIO.
News 
Market Data 
Discover 
